2,752
Views
13
CrossRef citations to date
0
Altmetric
Original Research

Rates of hospitalization among patients with deep vein thrombosis before and after the introduction of rivaroxaban

, , , , , & show all
Pages 85-93 | Received 27 Jan 2015, Accepted 18 Feb 2015, Published online: 19 Mar 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jeffrey Trocio, Virginia M Rosen, Anu Gupta, Oluwaseyi Dina, Lien Vo, Patrick Hlavacek & Lisa Rosenblatt. (2019) Systematic literature review of treatment patterns for venous thromboembolism patients during transitions from inpatient to post-discharge settings. ClinicoEconomics and Outcomes Research 11, pages 23-49.
Read now

Articles from other publishers (12)

Anna Södergren, Solbritt Rantapää-Dahlqvist & Lotta Ljung. (2023) Time Trends of Cardiovascular Disease in the General Population and Inflammatory Arthritis. Rheumatic Disease Clinics of North America 49:1, pages 1-17.
Crossref
Michael Styler, Sachi Singhal, Konstantine Halkidis, Parshva Patel, Kristine M Ward & Maneesh Jain. (2022) The Impact of Winter Months on Venous Thromboembolism (VTE) Patients: A Retrospective Analysis of Hospital Outcomes in the United States. Cureus.
Crossref
Brandon C. Maughan, Lisa Frueh, Marian S. McDonagh, Bryan Casciere & Jeffrey A. Kline. (2020) Outpatient Treatment of Low‐risk Pulmonary Embolism in the Era of Direct Oral Anticoagulants: A Systematic Review. Academic Emergency Medicine 28:2, pages 226-239.
Crossref
Li Yang & Jingjing Wu. (2020) Cost-effectiveness of rivaroxaban compared with enoxaparin plus warfarin for the treatment of hospitalised acute deep vein thrombosis in China. BMJ Open 10:7, pages e038433.
Crossref
K. Lobastov, A. Vorontsova, A. Bargandzhiya, I. Schastlivtsev & L. Laberko. (2020) Outpatient Treatment for Deep Vein Thrombosis with Rivaroxaban: A Single-Center Experience. Flebologiia 14:2, pages 99.
Crossref
Adam D. Porath, Sharon Clodfelter, Terra Slaton, Brahim K. Bookhart, Chris M. Kozma, Michelle L. Rand & Michael J. Bloch. (2019) Policy Change for Deep Vein Thrombosis: Effects on Length of Stay and Hospitalization Costs of Moving From Warfarin to Direct Oral Anticoagulants. Clinical Therapeutics 41:2, pages 269-279.
Crossref
Jan Beyer-Westendorf. (2018) What have we learned from real-world NOAC studies in venous thromboembolism treatment?. Thrombosis Research 163, pages 83-91.
Crossref
Catherine A Saint, Michelle R Castelli, Andrew J Crannage, Zachary A Stacy & Erin K Hennessey. (2017) Comparison of hospital length of stay in patients treated with non–vitamin K oral anticoagulants or parenteral agents plus warfarin for venous thromboembolism. SAGE Open Medicine 5, pages 205031211771962.
Crossref
Steven Deitelzweig, François Laliberté, Concetta Crivera, Guillaume Germain, Brahim K. Bookhart, William H. Olson, Jeffrey Schein & Patrick Lefebvre. (2016) Hospitalizations and Other Health Care Resource Utilization Among Patients with Deep Vein Thrombosis Treated with Rivaroxaban Versus Low-molecular-weight Heparin and Warfarin in the Outpatient Setting. Clinical Therapeutics 38:8, pages 1803-1816.e3.
Crossref
Serena Granziera, Arjumand Hasan & Alexander (Ander) T. Cohen. (2015) Direct Oral Anticoagulants and Their Use in Treatment and Secondary Prevention of Acute Symptomatic Venous Thromboembolism. Clinical and Applied Thrombosis/Hemostasis 22:3, pages 209-221.
Crossref
V. Tagalakis, M. Eberg, S. Kahn & L. Azoulay. (2016) Use of statins and reduced risk of recurrence of VTE in an older population. Thrombosis and Haemostasis 115:6, pages 1220-1228.
Crossref
Walter Ageno, Lorenzo G Mantovani, Sylvia Haas, Reinhold Kreutz, Danja Monje, Jonas Schneider, Martin van Eickels, Martin Gebel, Elizabeth Zell & Alexander G G Turpie. (2016) Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study. The Lancet Haematology 3:1, pages e12-e21.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.